Introduction
Tumor necrosis factor (TNF)-α is a multifunctional cytokine that regulates immunity, inflammation, cell differentiation, proliferation, and apoptosis [1, 2] . TNF-α binds to two distinct receptors, TNF receptor type 1 (TNFR1; CD120a) and TNF receptor type 2 (TNFR2; CD120b) [3] . Most of TNF functions are thought to be induced via TNFR1. TNFR1 is constitutively expressed in most tissues. TNFR1 recruits death-domain proteins including TNFR1-associated death domain protein (TRADD) and Fas-associated death domain proteins (FADDs) [4] . TRADD activates FADDs, receptor-interacting protein 1 (RIP1), and TNF receptor-associated factor 2 (TRAF2). TRAF2 and RIP1 activate mitogen-activated protein kinases (MAPKs), such as extracellular signal-regulated kinase (ERK), p38 MAPK, c-jun amino-terminal kinases (JNK), and nuclear factor-κB (NF-κB) [1, 2, [5] [6] [7] .
Toll-like receptors (TLRs) are pattern recognition receptors that recognize pathogen-associated molecular patterns (PAMPs) in the pathogen-derived molecules such as lipopolysaccharide (LPS) and induce innate immune responses. The TLR family consists of more than 13 members in mammals [8] . TLRs recognize various PAMPs, such as lipoproteins (TLR2), peptidoglycan (TLR2), double-stranded RNA (TLR3), LPS (TLR4), flagellin (TLR5), single-stranded RNA (TLR7 and TLR8), and CpG-DNA (TLR9). TLRs contain a Toll-IL-1R (TIR) domain [9, 10] . Upon TLR activation, TIR domain efficiently recruits several TIR-containing intracellular adaptor proteins including myeloid differentiation primary-response gene 88 (MyD88) [11, 12] and TIR domain-containing adaptor inducing interferon (IFN)-β (TRIF) [13, 14] . The MyD88-dependent signaling pathway activates MAPKs, NF-κB, phosphatidylinositol 3-kinase (PI3K)/Akt, activator protein-1, and IFN regulatory factor (IRF) 5 via TRAF6, which induces inflammatory cytokine synthesis. The TRIF-dependent signaling pathway activates IRF3, IRF7, and NF-κB via RIP1, TRAF3, and TRAF6, which induces type I IFNs [10, [15] [16] [17] [18] [19] . 4 Dendritic cells (DCs) are potent professional antigen-presenting cells and play important roles in the initiation and the regulation of immune responses to various pathogenic antigens [20] [21] [22] . TLR-stimulated DCs produce a large amount of inflammatory cytokines including TNF-α, interleukin (IL)-1, IL-6, and IL-12 and also anti-inflammatory cytokines such as IL-10.
DC-produced IL-12 drives polarization of naïve CD4 + T cells toward T helper type 1 (Th1) cells, while the IL-10 is involved in inhibition of Th1 responses and differentiation of regulatory T cells [23] [24] [25] [26] . It seems that the balance of inflammatory versus anti-inflammatory cytokines produced by DCs is crucial to control immune homeostasis. However, the mechanism underlying regulation of the cytokine balance has not been fully understood.
TNF-α exhibits not only proinflammatory functions but also displays anti-inflammatory properties [27] [28] [29] . It has been reported that TNF-α promotes IL-10 production by human monocytes [30, 31] , although molecular mechanism underlying the TNF-α-mediated regulation of IL-10 production remains unclear. On the other hand, the role of TNF-α for IL-10 production by DCs has not been well documented. In the present study, using bone-marrow derived DCs (BMDCs) generated from either wild type (WT) or TNF-α knockout (TNF-α -/-) mice, we examined the role of TNF-α in DC production of IL-10 upon TLR stimulation focusing on the intracellular signaling.
Materials and Methods

Mice
WT C57BL/6 mice were purchased from Japan SLC (Hamamatsu, Japan). TNF-α knockout (TNF-α -/-) mice with C57BL/6 background were obtained from The Jackson Laboratory (Bar Harbor, ME). All mice were maintained in a specific pathogen-free condition of our animal facility at Hokkaido University. Female mice at 6 to 14-weeks old were used for the 5 preparation of bone marrow cells. All experiments were approved by regulations of Hokkaido University Animal Care and Use Committee.
Reagents and antibodies (Abs)
Murine recombinant granulocyte-macrophage colony-stimulating factor (GM-CSF) and murine recombinant TNF-α were purchased from PeproTech (Rocky Hill, NJ 
Generation of BMDCs
Murine BMDCs were generated by a well established method as previously described [32, 33] with a minor modification. Bone marrow cells were prepared from femur and tibial bone marrow of WT or TNF-α -/-mice. After lysis of erythrocytes, major histocompatibility 6 complex class II-, CD45R (B220)-, CD4-, and CD8-positive cells were removed by killing with a cocktail of relevant mAbs (1E4, RA3-6B2, GK1.5, and 53-6.7) and rabbit complement. The cells were extensively washed to remove mAbs, complement, and cell debris. The cells were cultured in RPMI-1640 containing 5% fetal calf serum (FCS) and GM-CSF (20 ng/ml) at a density of 1 x 10 6 cells/ml/well (24-well plate). On day 2, the medium was gently exchanged to fresh medium. On day 4, non-adherent granulocytes were removed without dislodging clusters of developing DCs, and fresh medium was added. On day 6, free-floating and loosely adherent cells were collected and were used as BMDCs (>95% CD11c + B220 -).
Measurement of cytokines in culture supernatants
BMDCs (2 × 10 5 /ml) were treated with TNF-α and/or P3C (100 ng/ml) plus LPS (1 µg/ml) (This combination of TLR ligands will be referred to as TLR-L) for 24 h in 5% FCS RPMI-1640 [34] . TNF-α was used at 100 ng/ml based on our preliminary dose-response study (data not shown). In some experiments, cells (2 × 10 5 /ml) were pretreated with U0126, SB203580, LY294002, or vehicle alone (0.1% DMSO) for 1 h and then stimulated with TNF-α and/or TLR-L for 24 h in the presence of each inhibitor. U0126, SB203580, and LY294002
were used at 10, 30, and 10 µM, respectively, as previously described [34] . The culture supernatants were subjected to quantification of the protein level of IL-10, IL-12 p40, and TNF-α by enzyme linked immunosorbent assay (ELISA) using OptEIA Set (BD Pharmingen).
Immunoblotting
BMDCs (5 × 10 5 /ml) were treated with TLR-L and/or TNF-α for 24 h in 5% FCS RPMI-1640 for the indicated time period. Reactions were halted by rapidly cooling on ice, and these cells were washed by ice-cold phosphate-buffered saline. The whole cell lysates were prepared using cell lysis buffer (Cell signaling Technology). The cell lysates were separated by 7 sodium dodecyl sulfate-polyacrylamide gel electrophoresis, and then blotted onto a polyvinylidene fluoride membrane (Millipore, Bedford, MA). The membrane were proved with primary Ab, and developed with horseradish peroxidase-conjugated secondary Ab by enhanced chemiluminescence.
Flow cytometry
Cell staining with FITC-, PE-, or biotin-conjugated mAb, and streptavidin-PerCP and flow cytometric analysis was performed on EPICS XL (Beckman coulter Inc., Miami, FL) as previously described [35] .
Statistical analysis
The Student's t-test or Dunnet's test was used to analyze data for significant differences. P values less than 0.05 were regarded as significant.
Results
Cytokine production by WT and TNF-α -/-DCs upon TLR stimulation
We examined the role of endogenous TNF-α in IL-10 production by murine BMDCs in response to TLR ligands comparing BMDCs from TNF-α -/-mice and those from WT mice.
We have previously demonstrated that LPS (ultra-pure grade) or P3C (a synthetic TLR2 ligand) alone induced negligible production of IL-10 in BMDCs, while the simultaneous treatment with these ligands results in the vigorous production of IL-10 [34] . Thus, DCs were stimulated with LPS plus P3C to evaluate the ability for the IL-10 production.
BMDCs from WT or TNF-α -/-mice were treated with TLR-L (1 µg/ml LPS plus 100 ng/ml P3C) for 24 h, and levels of IL-10, IL-12 p40, and TNF-α in the culture supernatants were determined by ELISA (Fig. 1A) . Consistent with our previous study, TLR-L induced 8 substantial level of IL-10 production by WT DCs. Notably, IL-10 production by TNF-α -/-DCs stimulated with TLR-L was significantly suppressed as compared to that by WT DCs (Fig. 1A, left). In contrast, both WT DCs and TNF-α -/-DCs vigorously produced IL-12 p40 in response to TLR-L and no significant difference was detected in this cytokine production between these types of DCs (Fig. 1A, center) . WT DCs markedly produced TNF-α in response to TLR-L, while TNF-α -/-DCs showed no TNF-α production irrespective of the TLR stimulation (Fig. 1A, right). We also analyzed IL-12 p70 production by WT and TNF-α -/-DCs upon TLR stimulation.
However, no IL-12 p70 production was detected in any cultures tested (< 30 pg/ml, data not shown). No significant difference was detected in the cell viability between WT and TNF-α -/-DCs after 24 h of culture (data not shown).
The effect of exogenous TNF-α in IL-10 production by DCs upon TLR stimulation
Above findings (Fig. 1A) suggest that DC production of TNF-α lead to the IL-10 production by these DCs in response to TLR ligands. We next examined whether addition of exogenous TNF-α during the TLR stimulation recovered the impaired ability of TNF-α -/-DCs to produce IL-10.
BMDCs from WT or TNF-α -/-mice were stimulated with TLR-L in the presence or absence of TNF-α (100 ng/ml) for 24 h, and levels of IL-10 and IL-12 p40 in the culture supernatants were determined by ELISA (Fig. 1B) . TNF-α alone never induced IL-10 production by both types of DCs (Fig. 1B left) . TLR-L markedly induced IL-12 p40 production by WT DCs and TNF-α -/-DCs, and no significant difference was detected in the level of IL-12 p40 production between these types of DCs (Fig. 1B, middle) . Exogenous TNF-α never affected the TLR-mediated IL-12 p40
production by WT DCs. Although TNF-α slightly increased the TLR-mediated IL-12 p40
production by TNF-α -/-DCs, the effect was statistically not significant.
Cell surface expressions of maturation markers on TLR-stimulated DCs
We (Fig. 2) . Addition of TNF-α during the TLR stimulation showed no effect on the level of CD86, CD40, and I-A b expressions in both types of DCs (data not shown). From these results, TNF-α may be dispensable for the phenotypic maturation of DCs in response to TLR stimulation.
The effect of TNF-α on activation of Akt and MAPKs in DCs upon TLR stimulation
PI3K/Akt and MAPK pathways are responsible for production of various cytokines following TLR stimulation [36] . It has been reported that TNF-α is capable of activating these intracellular pathways [37, 38] . TNF-α promoted IL-10 production in TNF-α -/-DCs but not in WT DCs (Fig. 1) . To analyze the molecular mechanism responsible for the TNF-α-mediated promotion of IL-10 production seen in TNF-α -/-DCs, we examined the effect of TNF-α on activation of Akt and MAPKs (ERK1/2, p38 MAPK, and JNK1/2) in the TNF-α -/-DCs upon TLR stimulation.
BMDCs from TNF-α -/-mice were stimulated with TNF-α and/or TLR-L for indicated time periods, and intracellular protein levels of phospho-Akt (pAkt), phospho-ERK1/2 (pERK1/2), phospho-p38 MAPK (pp38 MAPK), and phospho-JNK1/2 (pJNK1/2) were determined by immunoblotting (Fig. 3) .
TNF-α markedly increased the level of pERK1/2 in TNF-α -/-DCs at 7 min, while showed only slight effect at 15 to 30 min (Fig. 3 A, B) . On the other hand, TLR-L induced slight phosphorylation of ERK1/2 in TNF-α -/-DCs at 7 min, but markedly increased the level at 15 min. The effect was decreased at 30 min. The pERK1/2 in TNF-α -/-DCs at 7 min after treatment with both TLR-L and TNF-α showed same level as that in TNF-α -/-DCs treated with TNF-α alone. Thus, the ERK1/2 activation at 7 min seemed to be largely dependent on TNF-α.
At 15 and 30 min no difference was detected in the pERK1/2 level between TLR-L-treated and
TLR-L plus TNF-α-treated TNF-α -/-DCs.
The levels of pp38 MAPK and pAkt in TNF-α -/-DCs were markedly increased at 7 min, and then gradually reduced at 15 to 30 min after TNF-α stimulation (Fig. 3 A, C, E) . In contrast, TLR-L increased the levels of these molecules slightly at 7 min, but markedly at 15 and 30 min.
Treatment of these DCs with both TNF-α and TLR-L considerably increased the levels of pp38
MAPK and pAkt at 7 min as compared with those in DCs treated with TLR-L alone. Thus, exogenous TNF-α was responsible for an early (7 min) activation of p38 MAPK and Akt.
The level of pJNK1/2 in TNF-α -/-DCs was modestly increased at 7 to 15 min and then decreased at 30 min after TNF-α stimulation (Fig. 3 A, D) . In contrast, TLR-L increased the level of pJNK1/2 modestly at 7 min and markedly at 15 and 30 min. Exogenous TNF-α, however, showed no significant effect on the TLR-L-mediated phosphorylation of pJNK1/2 at 11 all time periods tested.
The effect of ERK1/2, p38 MAPK, or PI3K inhibition on IL-10 and IL-12 p40 production by TNF-α -/-DCs upon TNF-α plus TLR-L stimulation
ERK1/2, p38 MAPK, and Akt activation in TNF-α -/-DCs upon TLR stimulation was significantly enhanced by addition of TNF-α at an early time point (Fig. 3) . We thus examined the role of ERK1/2, p38 MAPK, and Akt in IL-10 production by TNF-α -/-DCs upon stimulation with TLR-L plus TNF-α using U0126, a specific inhibitor of MEK-ERK pathway, SB203580, a specific inhibitor of p38 MAPK, and LY294002, a specific inhibitor of PI3K. It has been reported that p38 MAPK and Akt are activated via RIP1, while JNK was activated via TRAF2 in TNF-α-mediated cellular responses [6] . Thus, we speculate that RIP1 is crucial for the TNF-α-mediated effect on IL-10 production in TNF-α -/-DCs. On the other hand, Vivarelli et al showed that RIP1 is also involved in TLR4-mediated activation of PI3K-Akt pathway [41] . Thus, TNF-α-and TLR-mediated signaling pathways appear to share the RIP1.
TNF-α
Discussion
Consequently, we could not clarify whether the decrease in IL-10 production in response to MAPK and PI3K inhibitors (Fig. 4) is due to specific inhibition of the TNF-α-mediated signaling. Nonetheless, we believe that our present findings are important to understand a regulation system of IL-10 in DCs in response to TLR stimulation.
Recently, several studies also showed that MAPK-or PI3K-mediated signal is involved in IL-10 production and autocrine IL-10 negatively regulated IL-12 production upon TLR stimulation in macrophages and DCs [40] [41] [42] [43] . On the other hand, we have previously reported that LY294002 (a PI3K specific inhibitor) decreases IL-10 production, but shows no effect on IL-12 p40 production upon TLR-stimulation in BMDCs [34] . At present, decrease in IL-10 production by inhibiting PI3K activity showed no significant effect on IL-12 p40 production by 14 TNF-α -/-DCs stimulated with TLR-L plus TNF-α (Fig. 4) . The discrepancy between above studies in the autocrine inhibitory effect of IL-10 on IL-12 p40 production may be attributable to the differences in cell types and/or culture conditions such as cell density and stimuli.
We performed the blocking study using anti-TNF-α mAb (clone: MP6-XT22), anti-TNFR1 mAb (clone: 55R-170), and anti-TNFR2 mAb (clone: TR75-54.7). TNF-α-induced increase in CD86 expression on BC1 cells [35] was completely inhibited by treatment with the anti-TNFR1 mAb or the anti-TNF-α mAb (data not shown). However, these mAbs failed to exert significant effects on the IL-10 production by DCs upon the TLR stimulation (data not shown). As a possible explanation for the discrepant results, attenuated TNF-α signal in the presence of the mAb might be enough to enhance the TLR-mediated IL-10 production.
Alternatively, a constitutive weak TNF-α signaling before the antibody treatment might be sufficient to facilitate IL-10 production upon TLR stimulation.
We also analyzed production of IL-23, a member of the IL-12 cytokine family, in WT and TNF-α -/-DCs upon TLR stimulation. TLR ligands induced substantial production of IL-23 in WT and TNF-α -/-DCs. The IL-23 production by TNF-α -/-DCs was higher than that by WT DCs (data not shown). In contrast, the IL-12 p40 production upon the TLR stimulation slightly decreased in TNF-α -/-DCs compared to WT DCs (Fig. 1) . Thus, the level of IL-12 p40 production did not reflect to that of IL-23 production in our culture system. It has been shown that IL-12 p40 expression was not parallel to IL-23 p19 expression in DCs [44] . It seems to us that this point should be carefully analyzed in future studies.
We demonstrated herein that TNF-α signaling to promote DC production of anti-inflammatory cytokine, IL-10, but not inflammatory cytokine, IL-12, upon TLR stimulation. Thus, TNF-α may be a key molecule to regulate the balance between anti-inflammatory versus inflammatory cytokines in DCs. However, the precise mechanism underlying the TNF-α-mediated regulation of IL-10 production remains to be unclear. Thus, 15 we would like to identify the molecular mechanisms responsible for the TNF-α-mediated regulation system in the future studies. Since the balance between IL-10 and IL-12 production by DCs is crucial to induce appropriate immune responses, further elucidation of the TNF-α-mediated immune regulation may lead to the development of clinical applications for the treatment of various immune disorders. p<0.01; ***: p<0.001; NS: not significant). 
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